
NYSE:XYL
(A Top Pick February 17, 2017. Up 52.65%). This is a pure play on water, which she sees as a scarce resource. It treats and transports water. 70% of the world is water, but only 1% is drinkable. 21% of revenues is in emerging markets, which is a high-growth area for clean water. In the US, there is pent-up demand for upgrading water infrastructure, which XYL can provide. Still holds the stock for clients but waiting for a pullback before buying more.
(A Top Pick Jan 11/17. Up 43%.) There are not a lot of pure plays in this space. They transport, treat and test water. About 20% of revenues are from emerging markets. Those countries are still building out water infrastructure. In developed markets, water systems are aging and need refurbishment. She wouldn't chase the name at this price, but would wait for a bit of consolidation.
Based out of the US. They do water transportation, treatment and tests. There are not a lot of companies that focus in this space. She still likes it. The stock has done well, so the valuation is not as attractive as when she had purchased this in January. Emerging markets are about 20% of revenues and they are still building out their water infrastructures. In developed markets the water infrastructure is very old and needs to be updated.
An industrial company, so we are entering a time when industrial companies tend to do quite well. Technically, it is holding support at around its 50-day moving average. It has pulled back recently, but this is just alleviating a parabolic rise that we have seen since the start of the year. We should see support of their 50-day moving average. It is still producing higher highs and higher lows, and that trend is your friend.
This is water. Given the rise in world temperatures, and given the droughts in specific areas, water is going to be in a major scarcity mode. This company is a major player in that area. They are a very socially responsible company and recognize the problems, and are pouring more and more money into R&D. They are basically working with their customers in a broad range of water usage. They have a global orientation. Trading at 23.5X this year’s earnings which is somewhat expensive, but he is seeing consistent double-digit growth. Dividend yield of 1.3%. (Analysts’ price target is $55.)
This is a water stock. As the world focuses more and more on the need for clean water, they are looking for companies that essentially purify, transport and monitor the usage. This company is focusing on the high-tech part of the business, and just recently continued a completion of an acquisition of Sensus, which is going to add significantly to sales and earnings this year. (Analysts’ price target is $55.)
They are in the business of transportation, testing and treatment of water. Drinkable water is a very scarce commodity. 21% of revenues are from emerging markets. They are trying to give people access to sanitation. In the US there is a lot of overhaul required on the existing systems. In 2012 state governments cut back because there was no funding. XYL-N also have exposure in the UK. They just acquired a smart metering company and will do some cross selling. (Analysts’ target: $54.00).
This was a spin out from ITT Corp in 2011. They make water equipment and sources to the water industry. Their products encompass anywhere from water transportation (pumps, valves, controls), treatment and testing. Their end markets include municipalities, utilities, industrial clients, building services, commercial clients, and even the agricultural industry. 70% of the globe is made up of water, but only 1% is actually drinkable or potable. There is the issue of emerging markets, where they are still building out their water infrastructure. In the developed markets, there is the problem of aging infrastructure which needs replacement. Dividend yield of 1.26%. (Analysts’ price target is $53.58.)
(A Top Pick June 15/17, Up 37%) Transport, test, and treat water. Clients are utilities and commercial companies. A play on in the developed market, where water systems are old and need to be updated. Delayed impact as money is put back into infrastructure. Solid growth in Europe and US. Get 20% revenue from emerging markets, targeting China, India, and Middle East. Would buy on weakness, under $70. Christine’s price target 12 months out is about $80.